BeyondMD review

The price is public. The price you'd pay is not.

BeyondMD does something most compounders won't: it puts a number in the hero of every GLP-1 program page, before any intake. Semaglutide from $125. Tirzepatide from $199. Wegovy and Zepbound from $129 each. Then, on exactly one page in the entire catalog — /all-programs/glp-1-injections/ — it states what those numbers are the bottom of: "Your program includes a medical provider consultation fee of $34, with the program cost ranging from $139 to $449 per month, depending on your personalized treatment plan."

That ceiling is roughly 3.2 times the headline, and it is the single most useful sentence on the site. It appears once. Everywhere else, "Starting at $125" sits alone, reading like a rate.

• Compounded semaglutide, injection: starting at $125 — inside a $139–$449 band
• Compounded tirzepatide, injection: starting at $199 — same band; the page's own title tag still says $209
• Oral semaglutide: $149 in the hero, "$125 new pricing" directly beneath it, $149 again on the catalog card
• Oral tirzepatide: $249 in the hero, "$199.99 new pricing" beneath it, $249 on the catalog card
• Wegovy® / Zepbound®: starting at $129 each, correctly labeled FDA-approved
• Not included: the $34 consultation fee, and shipping on the oral programs — which is never priced anywhere on the site

Where inside that band you land is decided on a phone call. Every "GET STARTED" button on every GLP-1 page resolves to /pre-appointment-with-specialist/, which is a lead-capture form, not a cart: "Complete the form below to schedule your free, introductory consultation… Our Online Specialist will call you shortly." That page contains no dollar figures at all. And this is a choice rather than a missing feature — BeyondMD's lab tests, on the same site, have working add-to-cart buttons with exact prices.

We looked behind the page as well as at it, because a funnel that builds itself in the browser is where a real catalog usually hides. There isn't one. No hidden price list, and — worth saying plainly — no undisclosed cancellation fee either. What the bundle does show is that consult charges and eligibility are resolved server-side per state, and that phone and video consult modes carry "(Additional $)" upgrades whose amounts are empty in the live code, so they are not observable.

Named clinicians — the rarest thing on this roster

Most compounded-GLP-1 platforms name nobody. BeyondMD names eleven, and three carry full credential bios: John Marley Bernard Jr., MD (Jefferson Medical College, emergency medicine residency at SUNY Buffalo, board certified, 20 years in practice); Hollie Ann Hall, APRN-C (Baker University 2003, family nurse practitioner via University of Phoenix 2010, AANP certified); and Jordan Dorsey, NP (endocrinology, primary care, dermatology, urology). Those are checkable credentials attached to checkable names, and it is the strongest thing in BeyondMD's file.

It is undercut by carelessness on the same page. Dr Bernard is "Medical Director" on /our-providers/ and "Nurse Director" on the homepage. Jordan Dorsey's name is misspelled "Jordan Doresey" in his own heading. And /frequently-asked-questions/ is unfinished Lorem Ipsum — "Ut wisi enim ad minim veniam" — live right now, under the headings "Intensive Caring" and "Best of Care," on a healthcare site. Three phone numbers circulate across the site, two contact-email domains, and the informed-consent page on beyondmd.com is headed with a sibling brand's name.

PCOS is named. Postpartum is not.

For readers of this site the maternal record splits cleanly. Pregnancy and breastfeeding are addressed twice, as contraindications, in the right places: the compounded semaglutide page lists them alongside medullary thyroid cancer and MEN2, and the Wegovy page says "Do not use Wegovy if you: Are pregnant, planning to become pregnant, or breastfeeding." That is the label, stated where a patient reads it.

PCOS is named too, and as an actual qualifying condition rather than a keyword: both brand pages set eligibility at "a BMI of 27 or higher with at least one weight-related health factor, such as insulin resistance, prediabetes, PCOS, high blood pressure, or abnormal cholesterol." That is more than most of this market does — see our evidence review on GLP-1s and PCOS for what the research supports there. The word "postpartum," however, appears nowhere on the site, so claim no postpartum positioning from any of this.

The Terms have no refund policy at all

We read roughly 44 KB of BeyondMD's Terms of Service. The word "refund" does not appear once. There is no cancellation policy, no auto-renewal disclosure and no money-back guarantee in the document. The only reassurance of that kind — "You'll only be charged if approved for treatment" — lives on the /our-process/ marketing page and is not echoed contractually anywhere.

The Terms are not silent about everything, though. They contain an agreement that you "will not dispute the charges… with the payment method company"; binding JAMS arbitration in Kent County, Michigan, with jury-trial and class-action waivers; and a hard cap: "THE MAXIMUM AGGREGATE LIABILITY… IS $500." They also state you may fill the prescription at any pharmacy of your choice, which sits oddly against a mail-order compounded program. An absent refund policy is not the same as a punitive one, and we found no cancellation fee in the code — but it does mean nothing about getting your money back is written down.

Which states, exactly? The site says both.

On a single page load, the sitewide footer says BeyondMD provides "care to clients in all 50 states" — echoed on /about/ and /our-providers/ — while the /our-process/ FAQ and the homepage FAQ both say it "currently serves most U.S. states." No list is published anywhere. The site asks for a ZIP code, the code resolves eligibility server-side, and the runtime fallback message is "Sorry! There is no provider available in your state." We record the conservative reading. Do not plan a move around the footer's version.

Where the evidence sits

Confidence: medium. Every price here is first-party and public, which puts BeyondMD ahead of the quiz-gated field — but the site disagrees with itself across surfaces (stale title tags, two prices stacked on the oral pages, superseded figures on the catalog cards), disagrees with itself on state coverage, and routes the actual transaction to a phone call. The compounding pharmacy is not named; only category claims about licensed 503A and 503B facilities. The LegitScript seal is served live from LegitScript's own CDN rather than self-hosted, which is a stronger signal because LegitScript controls that host and revokes by changing what it serves — though the directory itself is gated, so we say the seal is displayed, not that certification is current. No FDA warning letter attaches to BeyondMD, Prescribery Corp., DTG II or SamaritanMD, and none appears in the February 2026 wave of 30 telehealth GLP-1 letters. What would change this rating is one edit: publish the $139–$449 band and the $34 fee on every program page instead of one, and publish the state list. Until then, treat the call as a quote, get the monthly figure and the shipping cost in writing, and know there is no refund clause behind either. If a fixed number you can read before you commit is what you want, CoreAge Rx is the comparison. Our weighting is published at scoring methodology.